5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride, 95.0%, 500g

2,5-Dioxopyrrolidin-1-yl 4,7,10,13,16,19,22,25-octaoxaoctacos-27-yn-1-oate, 95%, 250mg

5-(4-n-Propylphenyl)-5-oxovaleric acid, 95.0%, 1g

2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95%, 250mg

N-(2-Fluoro-phenyl)-2-hydroxy-benzamide, 95.0%, 1g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 32 mm, 30 m, 1 Piece(s)

5-bromo-3-chloro-1H-1,2,4-triazole, 95.0%, 1g

Diethyl 2,5-dichlorothieno[3,2-b]thiophene-3,6-dicarboxylate, 98%, 250mg

3-Fluoro-N-methylaniline, 97.0%, 5g

(2-Fluoro-5-(trifluoromethoxy)phenyl)methanamine hydrochloride, 97%, 250mg

(R)-4-N-Boc-2-Methyl-piperazine, 97.0%, 1g

1-(1-pyrrolidinyl)cyclopentanecarboxylic acid hydrochloride, 95.0%, 10g

(S)-2-Hydroxy-3-methylbutanoic acid, 95.0%, 5g